The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes

Table 1

Baseline characteristics.

Baseline characteristics	T-PEMF
	Active	Sham	All
	(𝑁=21)	(𝑁=19)	(𝑁=40)
Age, mean (sd) [range, years]	58.2 (12.9)* [35–85]	49.5 (11.9) [24–70]	54.0 (13.0) [24–85]
Duration of episodes (month)mean (sd)	2.2 (2.5)	3.2 (5.0)	2.7 (4.1)
% females	66.7%	63.2%	65.0%

* 𝑃≤.05.